Cholangiocarcinoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{cholangiocarcinoma}} | {{cholangiocarcinoma}} | ||
{{CMG}} | {{CMG}};{{AE}} {{PSK}} | ||
==Overview== | ==Overview== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for cholangiocarcinoma.<ref name=USPSTF>cholangiocarcinoma. U.S. Preventive Services Task Force.http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=cholangiocarcinoma</ref> | According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for cholangiocarcinoma.<ref name=USPSTF>cholangiocarcinoma. U.S. Preventive Services Task Force.http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=cholangiocarcinoma</ref> | ||
Revision as of 18:52, 9 November 2015
|
Cholangiocarcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangiocarcinoma screening On the Web |
|
American Roentgen Ray Society Images of Cholangiocarcinoma screening |
|
Risk calculators and risk factors for Cholangiocarcinoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for cholangiocarcinoma.[1]
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for cholangiocarcinoma.[1]
References
- ↑ 1.0 1.1 cholangiocarcinoma. U.S. Preventive Services Task Force.http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=cholangiocarcinoma